Discover 1,169 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,169
Effects of a Supervised Rehabilitation Program on Disease Severity in Spastic Ataxias
for
Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay,
Location: Montreal, Quebec, Saguenay
Sponsor: Laval University
Sex: All
Age: 16+
Code: NCT06261424
Recruiting
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
for
Alopecia Areata
Location: Montreal, Quebec, Boston MA, Toronto, Oakville,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07733765
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: Montreal, Ottawa, Quebec, Boston MA, Rochester NY,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase 3, Recruiting
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
Music Interventions for the Facilitation of Sleep in the Acute Geriatric Setting
for
Sleep Disturbance, Insomnia, Music Listening Intervention,
Location: Montreal
Sponsor: McGill University
Sex: All
Age: 65+
Code: NCT05398419
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Montreal, Ottawa, Quebec, New York NY, Westbury NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase 3, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Montreal, Schenectady NY, Boston MA, White Plains NY,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
Tranexamic Acid Use on Pain, Mobility and Bleeding Following Total Hip and Total Knee Arthroplasty
for
Postoperative Bleeding
Location: Montreal
Sponsor: St. Mary's Research Center, Canada
Sex: All
Age: 18+
Code: NCT06208267
Recruiting
Virtual Reality Music in Geriatric Inpatients
for
Older Adult, Hospitalization
Location: Montreal
Sponsor: St. Mary's Research Center, Canada
Sex: All
Age: 60+
Code: NCT06519253
Recruiting
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
for
Cancer of the Prostate, Anxiety
Location: Montreal
Sponsor: St. Mary's Research Center, Canada
Sex: All
Age: 18+
Code: NCT06363266
Recruiting
Interest of Functional Neuroimaging in Assessing Decision-making Capacity of Older People With Neurocognitive Disorders
for
Decision Making, Dementia, Aging
Location: Montreal
Sponsor: Centre Hospitalier Universitaire de Besancon
Sex: All
Age: 70+
Code: NCT03931148
Recruiting
New
A Single Patient Study of Sapropterin for Multisystem Smooth Muscle Dysfunction Syndrome
for
Multisystemic Smooth Muscle Dysfunction Syndrome
Location: Montreal
Sponsor: Gregor Andelfinger
Sex: All
Age: 0 - 18
Code: NCT07574034
Recruiting
LongVentKids Study
for
Prolonged Mechanical Ventilation in Pediatric Intensive Care Unit,
Location: Montreal
Sponsor: St. Justine's Hospital
Sex: All
Age: 0 - 18
Code: NCT04112459
Recruiting
Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood
for
Pediatric Cancer
Location: Montreal
Sponsor: St. Justine's Hospital
Sex: All
Age: 0 - 21
Code: NCT02242552
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma